SEC Filings for iShares Nasdaq Biotechnology Index Fund (IBB)

$ 129.22   -1.59 (-1.22%) Volume: 3.35m 12:19 PM EDT 27-May-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals105/08/2020
N-CEN/A[Amend] Annual Report for Registered Investment Companies105/08/2020
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals1405/05/2020
N-CSRSCertified Shareholder Report, Semi-Annual49405/05/2020
N-CSRCertified shareholder report of registered management investment companies91605/05/2020
497Definitive materials105/04/2020
497KSummary Prospectus for certain open-end management investment companies filed pursuant to Securities Act Rule 497(K)1205/01/2020
497KSummary Prospectus for certain open-end management investment companies filed pursuant to Securities Act Rule 497(K)1605/01/2020
485BXTNew effective date for post-effective amendment [Rule 485(b)(1)(iii)]404/30/2020
485BXTNew effective date for post-effective amendment [Rule 485(b)(1)(iii)]204/30/2020
485BXTNew effective date for post-effective amendment [Rule 485(b)(1)(iii)]304/30/2020
485BXTNew effective date for post-effective amendment [Rule 485(b)(1)(iii)]304/30/2020
497Definitive materials204/30/2020
497Definitive materials104/30/2020
485BXTNew effective date for post-effective amendment [Rule 485(b)(1)(iii)]304/30/2020
123456789101112131415